Startseite>>Signaling Pathways>> GPCR/G protein>> LPL Receptor>>Cenerimod

Cenerimod (Synonyms: ACT-334441)

Katalog-Nr.GC19100

Cenerimod (ACT-334441) ist ein potenter, selektiver und oral aktiver S1P1-Rezeptormodulator mit einem EC50 von 1 nM.

Products are for research use only. Not for human use. We do not sell to patients.

Cenerimod Chemische Struktur

Cas No.: 1262414-04-9

Größe Preis Lagerbestand Menge
10mM (in 1mL DMSO)
63,00 $
Auf Lager
2mg
36,00 $
Auf Lager
5mg
63,00 $
Auf Lager
10mg
117,00 $
Auf Lager
25mg
216,00 $
Auf Lager
50mg
378,00 $
Auf Lager
100mg
630,00 $
Auf Lager

Tel:(909) 407-4943 Email: sales@glpbio.com

Kundenbewertungen

Basiert auf Kundenrezensionen.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Cenerimod (ACT-334441) is a potent and orally available sphingosine 1-phosphate 1 receptor (S1P1) agonist extracted from patent WO 2016184939 A1 and WO 2011007324 A1, example 1, with an EC50 of 2.7 nM.

References:
[1]. WO 2016184939 A1
[2]. WO 2011007324 A1

Bewertungen

Review for Cenerimod

Average Rating: 5 ★★★★★ (Based on Reviews and 28 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Cenerimod

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.